Abstract
INTRODUCTION
TOMM40 and APOC1 variants can modulate the APOE-ε4-related Alzheimer’s disease (AD) risk by up to fourfold. We aim to investigate whether the genetic modulation of ε4-related AD risk is reflected in brain morphology.
METHODS
We tested whether 27 magnetic resonance imaging-derived neuroimaging markers of neurodegeneration (volume and thickness in temporo-limbic regions) are associated with APOE-TOMM40-APOC1 polygenic profiles using the National Alzheimer’s Coordinating Center Uniform Data Set linked to the AD Genetic Consortium data.
RESULTS
All brain regions studied using structural phenotypes were smaller in individuals with AD. The ε4 allele was associated with smaller limbic (entorhinal, hippocampus, parahippocampus) brain volume and cortical thickness in AD cases than controls. There were significant differences in the associations for the higher-risk and lower-risk ε4-bearing APOE-TOMM40-APOC1 profiles with temporo-limbic region markers.
DISCUSSION
The APOE-AD heterogeneity may be partly attributed to the modulating role of the TOMM40 and APOC1 genes in the APOE cluster.
Highlights
The ε4 allele is associated with smaller values of neuroimaging markers in AD cases.
Larger values of neuroimaging markers may protect against AD in the ε4 carriers.
TOMM40 and APOC1 variants differentiate AD risk in the ε4 carriers.
The same variants can differentiate the links between ε4 and neuroimaging markers.
If you do not see content above, kindly GO TO SOURCE.
Not all publishers encode content in a way that enables republishing at Neuro.vip.
This post is Copyright: Alexander M. Kulminski,
Ethan Jain‐Washburn,
Alireza Nazarian,
Heather M. Wilkins,
Olivia Veatch,
Russell H. Swerdlow,
Robyn A. Honea | December 23, 2024